Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Only two standard parameters were studied: body weight and survival. Background concentration in the diet varied between 0.1 and 1.0% of SiO2 (w/w). Nitrogen and phosphorous retention/excretion was measured only in the males at the end of the exposure period. For justification of read across see endpoint summary.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Effects of soluble silica on growth, nutrient balance and reproductive performance of albino rats.
Author:
Smith, G. S. et al.
Year:
1973
Bibliographic source:
J. Animal Sc. 36|(2), 271-278.
Reference Type:
secondary source
Title:
Unnamed
Year:
2004

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Oral exposure of weanling rats via drinking water for 180 days.
The study was conducted to assess the influence of silica in the diet on growth and nutrient balance.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Reference substance name:
Silicic acid, sodium salt
EC Number:
215-687-4
EC Name:
Silicic acid, sodium salt
Cas Number:
1344-09-8
IUPAC Name:
sodium hydroxy(oxo)silanolate
Details on test material:
SOURCE: Diamond Alkali Company, Cleveland, Ohio, USA
PURITY: Not indicated
IMPURITY/ADDITIVE/ETC.: Not indicated
ANY OTHER INFORMATION: Molar ratio 3.2. Background concentration in the diet varied between 0.1 and 1.0% of SiO2 (w/w). Test substance Sodium Silicate was used.

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ORGANISMS
- Age: Weanling

Administration / exposure

Route of administration:
oral: drinking water
Vehicle:
water
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
180 d (m-f) + 17 days (m)
Frequency of treatment:
daily
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
789.5 and 1587 mg sodium  silicate/L
Basis:
nominal in water
Remarks:
Doses / Concentrations:
600 and 1200 mg SiO2/l
Basis:

No. of animals per sex per dose:
6
Control animals:
yes
Details on study design:
Post-exposure period: no

Examinations

Observations and examinations performed and frequency:
CLINICAL OBSERVATIONS AND FREQUENCY: 
- Mortality: registered with unknown frequency
- Body weight: registered every week
- Urinalysis: nitrogen and phosphorous registered daily from day 181-197 in males. 
Other examinations:
Analysis of faeces: nitrogen and phosphorous registered daily from day 181-197 in males.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not specified
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
not specified
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified
Details on results:
TOXIC RESPONSE/EFFECTS BY DOSE LEVEL: 
- Mortality and time to death: None
- Clinical signs: no effects
- Body weight gain: Some statistically significant differences in body weight between experimental groups and controls were registered, but these were small (6% or less), not consistent and not dose related.
- Urinalysis: significant, but not dose-related effects on nitrogen and  phosphorus retention (p<0.05)
- Other: In the male low dose group nitrogen retention was 50% lower that in the control group, while in the high dose group no such difference was observed. In a repeat experiment no clear and significant differences in nitrogen retention were found. In both experiments phosphorous retention seemed somewhat increased in the male high dose groups (approximately 12%), while in the low dose groups no effect of treatment was seen.

Effect levels

Dose descriptor:
NOAEL
Effect level:
> 159 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects observed

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
The NOAEL in rats after repeated oral administration of sodium silicate over 180 days was dertemined to be > 159 mg/kg bw/day.
Executive summary:

In a subchronic toxicity study sodium silicate was administered to 6 Sprague-Dawley rats /sex/dose in drinking water at dose levels of 79 and 159 mg/kg bw/day.

TOXIC RESPONSE/EFFECTS BY DOSE LEVEL:

- Mortality and time to death: None

- Clinical signs: no effects

- Body weight gain: Some statistically significant differences in body weight between experimental groups and controls were registered, but these were small (6% or less), not consistent and not dose related.

- Urinalysis: significant, but not dose-related effects on nitrogen and phosphorus retention (p<0.05)

- Other: In the male low dose group nitrogen retention was 50% lower that in the control group, while in the high dose group no such difference was observed. In a repeat experiment no clear and significant differences in nitrogen retention were found. In both experiments phosphorous retention seemed somewhat increased in the male high dose groups (approximately 12%), while in the low dose groups no effect of treatment was seen.

The NOAEL is > 159 mg/kg bw/day.